sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
ALKS
Updated 10/6/2026, 3:28 PM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| ALKS Alkermes plc. | Sale | $83,455 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,034 sh | at $41.03 | Filed Oct 2, 6:22 PM ET | Filing | |
| ALKS Alkermes plc. | Sale | $97,652 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,034 sh | at $48.01 | Filed Sep 3, 6:32 PM ET | Filing | |
| ALKS Alkermes plc. | Sale | $422,874 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 sh | at $46.99 | Filed Sep 1, 7:08 PM ET | Filing | |
| ALKS Alkermes plc. | Sale | $372,937 | Nichols Christian Todd SVP, Chief Commercial Officer | 7,576 sh | at $49.23 | Filed Aug 17, 6:53 PM ET | Filing | |
| ALKS Alkermes plc. | Sale | $2,239,076 | snyderman nancy lynn MD Director | 44,472 sh | at $50.35 | Filed Aug 3, 7:16 PM ET | Filing | |
| ALKS Alkermes plc. | Sale | $437,220 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 sh | at $48.58 | Filed Aug 3, 7:12 PM ET | Filing | |
| ALKS Alkermes plc. | Sale | $98,812 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,034 sh | at $48.58 | Filed Aug 3, 7:09 PM ET | Filing |